COVID-19 vaccine development, enrollment and funding status July 28, 2020, by company
By the end of the year, over 180,000 individuals are expected to take part in phase 3 clinical trials for vaccinations against coronavirus. Of the six trials listed, four have acquired U.S. taxpayer funding through the Biomedical Advanced Research and Development Authority (BARDA) or "U.S. Project Warp Speed". This statistic shows the number of expected phase 3 participants and BARDA/Warp Speed funding status of selected COVID-19 vaccines, by company, as of July 28, 2020.